Trump’s 2021 bud­get re­quest seeks mod­est fund­ing in­crease for FDA

The Trump ad­min­is­tra­tion on Mon­day un­veiled its FY 2021 bud­get pro­pos­al, seek­ing a 10% re­duc­tion in over­all fund­ing for the De­part­ment of Health and Hu­man Ser­vices (HHS), but a slight in­crease in fund­ing for the FDA.

For the FDA, the bud­get re­quests $6.2 bil­lion over­all, in­clud­ing $3.3 bil­lion in dis­cre­tionary bud­get au­thor­i­ty (BA) and $2.9 bil­lion in user fees.

Steven Gross­man, deputy ex­ec­u­tive di­rec­tor of the Al­liance for a Stronger FDA, told Fo­cus that his group’s pre­lim­i­nary analy­sis is that the pro­pos­al in­cludes a $46 mil­lion in­crease in the BA (tax­pay­er fund­ed) ap­pro­pri­a­tions, which in­cludes $21 mil­lion in ad­di­tion­al funds for de­vices, $2 mil­lion in ad­di­tion­al funds for pro­grams in the FDA com­mis­sion­er’s of­fice and $24 mil­lion in to­tal rent items. Off­set­ting this are: $1 mil­lion in de­creas­es for an­i­mal drugs and the Na­tion­al Cen­ter for Tox­i­co­log­i­cal Re­search, the al­liance said.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.